Skip to Main Content

OTLK  Outlook Therapeutics Inc
Common Stock
NASDAQ

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Officers:

Key Statistics & Ratios

Price & Volume
Previous Close$1.43
52 Week High (02/14/2019)$10.96
52 Week Low (04/25/2019)$1.32
Average Daily Volume1.58M
Beta--
Per Share Data
Earnings (TTM)-$7.24
Sales (MRQ)$0.51
Book Value (MRQ)-$2.24
Cash Flow (TTM)-$5.17
Financial Strength (MRQ)
Quick Ratio0.00
Current Ratio0.08
Long Term Debt/Equity--
Total Debt/Equity--
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)2.79x
Price/Book (MRQ)--
Price/Cash Flow (TTM)--
Dividend Information
Dividend--
Ann. Dividend Yield--
Ex Div Date--
Payout Ratio (TTM)0.00%
Management Effectiveness (TTM)
Return on Equity--
Return on Assets-147.43%
Return on Investment Capital--
Share Statistics
Market Capitalization$29.17 M
Shares Outstanding11.76M
Float2.44M
Profitability (TTM)
Gross Margin--
Profit Margin-1,120.61%
MRQ = Most Recent QuarterTTM = Trailing Twelve MonthsN/A = Not AvailableN/M = Not Meaningful
Company Profile
Company Profile
KeyValue
Address7 Clarke Drive
Cranbury, NJ 08512
Phone+1 609 619-3990
Number of Employees56
IndustryBiotechnology
SectorHealthcare
Website
Email
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window